The DOI matches its Crossref record; 54 of the 54 references it cites were found in a registry or an index.
The Juxtamembrane Region of the EGF Receptor Functions as an Activation Domain
Open accessAbstract
SUMMARY In several growth factor receptors, the intracellular juxtamembrane (JM) region participates in autoinhibitory interactions that must be disrupted for tyrosine kinase activation. Using alanine scanning mutagenesis and crystallographic approaches, we define a domain within the JM region of the epidermal growth factor receptor (EGFR) that instead plays an activating – rather than autoinhibitory – role. Mutations in the C-terminal 19 residues of the EGFR JM region abolish EGFR activation. In a crystal structure of an asymmetric dimer of the tyrosine kinase domain, the JM region of an acceptor monomer makes extensive contacts with the C-lobe of a donor monomer, thus stabilizing the dimer. We describe how an uncharacterized lung cancer mutation in this JM activation domain (V665M) constitutively activates EGFR by augmenting its capacity to act as an acceptor in the asymmetric dimer. This JM mutant promotes cellular transformation by EGFR in vitro and is tumorigenic in a xenograft assay.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
[20] Processing of X-ray diffraction data collected in oscillation mode
Otwinowski, Z., & Minor, W. (1997) · Methods in Enzymology · doi:10.1016/s0076-6879(97)76066-x · Cited by 33,475
Coot : model-building tools for molecular graphics
Emsley, P., & Cowtan, K. (2004) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444904019158 · Cited by 30,571
The PyMOL Molecular Graphics System
DeLano, W. L. (2002) · Medical Entomology and Zoology · Cited by 18,147
The CCP4 suite: programs for protein crystallography
Collaborative Computational Project, N. 4. (1994) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444994003112 · Cited by 17,270
Crystallography & NMR System: A New Software Suite for Macromolecular Structure Determination
Brünger, A. T., Adams, P. D., Clore, G. M., DeLano, W. L., Gros, P., Grosse-Kunstleve, R. W., Jiang, J. S., Kuszewski, J., Nilges, M., Pannu, N. S., et al. (1998) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444998003254 · Cited by 15,715
Cell Signaling by Receptor Tyrosine Kinases
Lemmon, M. A., & Schlessinger, J. (2010) · Cell · doi:10.1016/j.cell.2010.06.011 · Cited by 7,929
Self-citationStructure validation by Cα geometry: ϕ,ψ and Cβ deviation
Lovell, S. C., Davis, I. W., Arendall, W. B., de Bakker, P. I. W., Word, J. M., Prisant, M. G., Richardson, J. S., & Richardson, D. C. (2003) · Proteins: Structure, Function, and Bioinformatics · doi:10.1002/prot.10286 · Cited by 4,595
Cell Signaling by Receptor Tyrosine Kinases
Schlessinger, J. (2000) · Cell · doi:10.1016/s0092-8674(00)00114-8 · Cited by 3,774
Epidermal growth factor receptor mutations in lung cancer
Sharma, S. V., Bell, D. W., Settleman, J., & Haber, D. A. (2007) · Nature Reviews Cancer · doi:10.1038/nrc2088 · Cited by 3,170
EGFR Antagonists in Cancer Treatment
Ciardiello, F., & Tortora, G. (2008) · New England Journal of Medicine · doi:10.1056/nejmra0707704 · Cited by 2,058
Erlotinib in Lung Cancer — Molecular and Clinical Predictors of Outcome
Tsao, M.-S., Sakurada, A., Cutz, J.-C., Zhu, C.-Q., Kamel-Reid, S., Squire, J., Lorimer, I., Zhang, T., Liu, N., Daneshmand, M., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa050736 · Cited by 1,830
The Conformational Plasticity of Protein Kinases
Huse, M., & Kuriyan, J. (2002) · Cell · doi:10.1016/s0092-8674(02)00741-9 · Cited by 1,752
Use of TLS parameters to model anisotropic displacements in macromolecular refinement
Winn, M. D., Isupov, M. N., & Murshudov, G. N. (2001) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444900014736 · Cited by 1,696
An allosteric mechanism for activation of the kinase domain of epidermal growth factor receptor
Zhang, X., Gureasko, J., Shen, K., Cole, P. A., & Kuriyan, J. (2006) · Cell · doi:10.1016/j.cell.2006.05.013 · Cited by 1,650
Stamos, J., Sliwkowski, M. X., & Eigenbrot, C. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m207135200 · Cited by 1,574
Shape Complementarity at Protein/Protein Interfaces
Lawrence, M. C., & Colman, P. M. (1993) · Journal of Molecular Biology · doi:10.1006/jmbi.1993.1648 · Cited by 1,215
Shape complementarity at protein–protein interfaces
Norel, R., Lin, S. L., Wolfson, H. J., & Nussinov, R. (1994) · Biopolymers · doi:10.1002/bip.360340711 · Cited by 1,208
Yun, C.-H., Boggon, T. J., Li, Y., Woo, M. S., Greulich, H., Meyerson, M., & Eck, M. J. (2007) · Cancer Cell · doi:10.1016/j.ccr.2006.12.017 · Cited by 1,192 · cited 16×
“However, in overlays of all known active and inactive EGFR TKD structures (including the structure described here), the positions of these three residues do not change.”
InfluentialLikelihood-enhanced fast rotation functions
Storoni, L. C., McCoy, A. J., & Read, R. J. (2004) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444903028956 · Cited by 1,172
A Unique Structure for Epidermal Growth Factor Receptor Bound to GW572016 (Lapatinib)
Wood, E. R., Truesdale, A. T., McDonald, O. B., Yuan, D., Hassell, A., Dickerson, S. H., Ellis, B., Pennisi, C., Horne, E., Lackey, K., et al. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-1168 · Cited by 1,122
Nuclear localization of EGF receptor and its potential new role as a transcription factor
Lin, S.-Y., Makino, K., Xia, W., Matin, A., Wen, Y., Kwong, K. Y., Bourguignon, L., & Hung, M.-C. (2001) · Nature Cell Biology · doi:10.1038/ncb0901-802 · Cited by 1,064
Insect cell-expressed p180erbB3 possesses an impaired tyrosine kinase activity.
Guy, P. M., Platko, J. V., Cantley, L. C., Cerione, R. A., & Carraway, K. L. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.17.8132 · Cited by 698 · cited 3×
“Interestingly, alignment of EGFR (ErbB-1) and ErbB-3 JM sequences (Figure 1A) shows that the EGFR T669, which is conserved in both ErbB-2 and -4, is an aspartate in ErbB-3, consistent with reports that ErbB-3 has little or no kinase activity (Guy et al., 1994).”
InfluentialHunter, T., Ling, N., & Cooper, J. A. (1984) · Nature · doi:10.1038/311480a0 · Cited by 645
The Structural Basis for Autoinhibition of FLT3 by the Juxtamembrane Domain
Griffith, J., Black, J., Faerman, C., Swenson, L., Wynn, M., Lu, F., Lippke, J., & Saxena, K. (2004) · Molecular Cell · doi:10.1016/s1097-2765(03)00505-7 · Cited by 499
ErbB receptors: new insights on mechanisms and biology
LINGGI, B., & CARPENTER, G. (2006) · Trends in Cell Biology · doi:10.1016/j.tcb.2006.10.008 · Cited by 377
Self-citationLee, J. C., Vivanco, I., Beroukhim, R., Huang, J. H. Y., Feng, W. L., DeBiasi, R. M., Yoshimoto, K., King, J. C., Nghiemphu, P., Yuza, Y., et al. (2006) · PLoS Medicine · doi:10.1371/journal.pmed.0030485 · Cited by 367
Wybenga-Groot, L. E., Baskin, B., Ong, S. H., Tong, J., Pawson, T., & Sicheri, F. (2001) · Cell · doi:10.1016/s0092-8674(01)00496-2 · Cited by 338
Juxtamembrane autoinhibition in receptor tyrosine kinases
Hubbard, S. R. (2004) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1399 · Cited by 325
Chou, T.-Y., Chiu, C.-H., Li, L.-H., Hsiao, C.-Y., Tzen, C.-Y., Chang, K.-T., Chen, Y.-M., Perng, R.-P., Tsai, S.-F., & Tsai, C.-M. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-1981 · Cited by 317
Structure of a c-Kit Product Complex Reveals the Basis for Kinase Transactivation
Mol, C. D., Lim, K. B., Sridhar, V., Zou, H., Chien, E. Y. T., Sang, B.-C., Nowakowski, J., Kassel, D. B., Cronin, C. N., & McRee, D. E. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.c300186200 · Cited by 274
Characterization of a Novel Tripartite Nuclear Localization Sequence in the EGFR Family
Hsu, S.-C., & Hung, M.-C. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m610014200 · Cited by 260
Ligand-induced ErbB receptor dimerization
Lemmon, M. A. (2009) · Experimental Cell Research · doi:10.1016/j.yexcr.2008.10.024 · Cited by 216
Self-citationNorthwood, I. C., Gonzalez, F. A., Wartmann, M., Raden, D. L., & Davis, R. J. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)98612-6 · Cited by 209
Binns, K. L., Taylor, P. P., Sicheri, F., Pawson, T., & Holland, S. J. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.13.4791-4805.2000 · Cited by 204
Walton, G. M., Chen, W. S., Rosenfeld, M. G., & Gill, G. N. (1990) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)40080-x · Cited by 192
Mechanism of Activation and Inhibition of the HER4/ErbB4 Kinase
Qiu, C., Tarrant, M. K., Choi, S. H., Sathyamurthy, A., Bose, R., Banjade, S., Pal, A., Bornmann, W. G., Lemmon, M. A., Cole, P. A., et al. (2008) · Structure · doi:10.1016/j.str.2007.12.016 · Cited by 191
Self-citationJiang, J., Greulich, H., Jänne, P. A., Sellers, W. R., Meyerson, M., & Griffin, J. D. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-1829 · Cited by 186
Bao, J., Alroy, I., Waterman, H., Schejter, E. D., Brodie, C., Gruenberg, J., & Yarden, Y. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m002367200 · Cited by 173
The HER family and cancer: emerging molecular mechanisms and therapeutic targets
Sergina, N. V., & Moasser, M. M. (2007) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2007.10.002 · Cited by 172
Autoinhibition of the Kit Receptor Tyrosine Kinase by the Cytosolic Juxtamembrane Region
Chan, P. M., Ilangumaran, S., La Rose, J., Chakrabartty, A., & Rottapel, R. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.9.3067-3078.2003 · Cited by 161
Takishima, K., Griswold-Prenner, I., Ingebritsen, T., & Rosner, M. R. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.6.2520 · Cited by 159
Thiel, K. W., & Carpenter, G. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0703854104 · Cited by 158
Self-citationMcLaughlin, S., Smith, S. O., Hayman, M. J., & Murray, D. (2005) · The Journal of General Physiology · doi:10.1085/jgp.200509274 · Cited by 135
Wood, E. R., Shewchuk, L. M., Ellis, B., Brignola, P. S., Brashear, R. L., Caferro, T. R., Dickerson, S. H., Dickson, H. D., Donaldson, K. H., Gaul, M. D., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0708281105 · Cited by 113
Li, X., Huang, Y., Jiang, J., & Frank, S. J. (2008) · Cellular Signalling · doi:10.1016/j.cellsig.2008.08.006 · Cited by 111
The Human Epidermal Growth Factor Receptor Contains a Juxtamembrane Calmodulin-Binding Site
Martín‐Nieto, J., & Villalobo, A. (1998) · Biochemistry · doi:10.1021/bi971765v · Cited by 98
Pallis, A. G., Voutsina, A., Kalikaki, A., Souglakos, J., Briasoulis, E. C., Murray, S. J., Koutsopoulos, A. V., Tripaki, M., Stathopoulos, E. N., Mavroudis, D., et al. (2007) · British Journal of Cancer · doi:10.1038/sj.bjc.6604068 · Cited by 90
Heisermann, G. J., Wiley, H. S., Walsh, B. J., Ingraham, H. A., Fiol, C. J., & Gill, G. N. (1990) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)38233-x · Cited by 89
He, C., Hobert, M. E., Friend, L., & Carlin, C. R. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m104646200 · Cited by 87
Choi, S. H., Mendrola, J. M., & Lemmon, M. A. (2006) · Oncogene · doi:10.1038/sj.onc.1209957 · Cited by 86
Self-citationKil, S. J., Hobert, M. E., & Carlin, C. R. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.5.3141 · Cited by 81
A negative feedback loop attenuates EGF-induced morphological changes.
Welsh, J. B., Gill, G. N., Rosenfeld, M. G., et al. (1991) · The Journal of Cell Biology · doi:10.1083/jcb.114.3.533 · Cited by 81
Kil, S. J., & Carlin, C. R. (2000) · Journal of Cellular Physiology · Cited by 67
A basic peptide within the juxtamembrane region is required for EGF receptor dimerization
Aifa, S., Aydin, J., Nordvall, G., et al. (2004) · Experimental Cell Research · doi:10.1016/j.yexcr.2004.08.032 · Cited by 61
Cited by
Cell Signaling by Receptor Tyrosine Kinases
Lemmon, M. A., & Schlessinger, J. (2010) · Cell · doi:10.1016/j.cell.2010.06.011 · Cited by 7,929
Self-citationMechanisms of receptor tyrosine kinase activation in cancer
Du, Z., & Lovly, C. M. (2018) · Molecular Cancer · doi:10.1186/s12943-018-0782-4 · Cited by 1,066
Rational, biologically based treatment of EGFR-mutant non-small-cell lung cancer
Pao, W., & Chmielecki, J. (2010) · Nature Reviews Cancer · doi:10.1038/nrc2947 · Cited by 1,083
The ERBB network: at last, cancer therapy meets systems biology
Yarden, Y., & Pines, G. (2012) · Nature Reviews Cancer · doi:10.1038/nrc3309 · Cited by 988
A Structural Perspective on the Regulation of the Epidermal Growth Factor Receptor
Kovacs, E., Zorn, J. A., Huang, Y., Barros, T., & Kuriyan, J. (2015) · Annual Review of Biochemistry · doi:10.1146/annurev-biochem-060614-034402 · Cited by 371
Metadata
- Authors
- Red Brewer, M., Choi, S. H., Alvarado, D., Moravcevic, K., Pozzi, A., Lemmon, M. A., & Carpenter, G.
- Venue
- Molecular Cell
- Publisher
- Elsevier BV
- Published
- 2009-06
- Volume
- 34
- Issue
- 6
- Pages
- 641-651
- ISSN
- 1097-2765 (ISSN-L)
- OpenAlex
- W2050046701
- Cited by
- 317
- References
- 54
- FWCI
- 12.08
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.